Procyanidin B2 inhibits angiogenesis and cell growth in oral squamous cell carcinoma cells through the vascular endothelial growth factor (VEGF)/VEGF receptor 2 (VEGFR2) pathway

This study aimed to explore the therapy role of procyanidin B2 (PB2) in inhibiting angiogenesis and cell growth in oral squamous cell carcinoma. After oral mucosa epithelial cell (OMEC) and human oral squamous cell carcinoma (OSCC) cell line (SCC-25) were treated with PB2 or SCC-25 were treated with...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Qiurong, Zhang, Taiyang, Xiao, Qingchun, Mei, Bingxin, Zhang, Xingwang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8973926/
https://www.ncbi.nlm.nih.gov/pubmed/35220896
http://dx.doi.org/10.1080/21655979.2022.2033013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8973926/
https://www.ncbi.nlm.nih.gov/pubmed/35220896
http://dx.doi.org/10.1080/21655979.2022.2033013

Ejemplares similares